An additional drug repurposing study for hidradenitis suppurativa/acne inversa

C. C. Zouboulis; B. Readhead; J. T. Dudley

doi:10.1111/bjd.19627

An additional drug repurposing study for hidradenitis suppurativa/acne inversa

C. C. Zouboulis, B. Readhead, J. T. Dudley

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	748-750
Number of pages	3
Journal	British Journal of Dermatology
Volume	184
Issue number	4
DOIs	https://doi.org/10.1111/bjd.19627
State	Published - Apr 2021
Externally published	Yes

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/bjd.19627

Cite this

@article{e940d859bcc04592b4c49045e6215f6e,

title = "An additional drug repurposing study for hidradenitis suppurativa/acne inversa",

author = "Zouboulis, {C. C.} and B. Readhead and Dudley, {J. T.}",

note = "Funding Information: sources: This work was partially funded by a research grant to C.C.Z. from the German Federal Ministry of Education and Research (BMBF) [Project 0313660 {\textquoteleft}Investigation of gene expression in apocrine glands of patients with acne inversa (hidradenitis suppurativa){\textquoteright}] and Unilever R & D, Port Sunlight, Birmingham, UK.The Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany comprise a healthcare unit of the European Reference Network for Rare and Complex Skin Diseases (ERN Skin). Open access funding enabled and organized by ProjektDEAL.",

year = "2021",

month = apr,

doi = "10.1111/bjd.19627",

language = "English (US)",

volume = "184",

pages = "748--750",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - An additional drug repurposing study for hidradenitis suppurativa/acne inversa

AU - Zouboulis, C. C.

AU - Readhead, B.

AU - Dudley, J. T.

N1 - Funding Information: sources: This work was partially funded by a research grant to C.C.Z. from the German Federal Ministry of Education and Research (BMBF) [Project 0313660 ‘Investigation of gene expression in apocrine glands of patients with acne inversa (hidradenitis suppurativa)’] and Unilever R & D, Port Sunlight, Birmingham, UK.The Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany comprise a healthcare unit of the European Reference Network for Rare and Complex Skin Diseases (ERN Skin). Open access funding enabled and organized by ProjektDEAL.

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85096838990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096838990&partnerID=8YFLogxK

U2 - 10.1111/bjd.19627

DO - 10.1111/bjd.19627

M3 - Letter

C2 - 33095911

AN - SCOPUS:85096838990

SN - 0007-0963

VL - 184

SP - 748

EP - 750

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 4

ER -

An additional drug repurposing study for hidradenitis suppurativa/acne inversa

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this